News
T O APPRECIATE the dilemmas the Food and Drug Administration (FDA) faces when it reviews new drugs targeting rare diseases, ...
The July CPI is expected to show a rise in annual retail inflation. AMC and Cisco among those reporting earnings. Nvidia ...
Ukraine and its European allies sought on Sunday to present a united front ahead of a meeting this week between President ...
The Food and Drug Administration (FDA) is hitting some speed bumps in implementing the Trump campaign agenda, and the ...
At the U.S. Food and Drug Administration's (FDA) request, Vinay Prasad is returning to the role of director of the Center for ...
Vinay Prasad is returning to his role overseeing vaccine, gene therapy and blood product regulation at the U.S. Food and Drug ...
Less than weeks after stepping down, Prasad will return to lead CBER “at the FDA’s request,” according to an HHS spokesperson ...
Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last month, is set to return to ...
Dr. Vinay Prasad’s rehiring was an unusual instance of a federal official targeted by the right-wing activist Laura Loomer ...
After exiting the FDA less than two weeks ago for unclear reasons, Vinay Prasad is once again director of the Center for ...
1d
TipRanks on MSNVinay Prasad returns to FDA as head of CBERVinay Prasad is returning to the Food and Drug Administration to lead the Center for Biologics Evaluation and Research. Prasad left the agency ...
Vinay Prasad, M.D., has rejoined the FDA, the latest turn in a monthslong stretch of leadership turnover at the agency. | “At ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results